New CAR-T therapy aims to tackle tough lymphoma
Disease control
Not yet recruiting
This study tests a new treatment called TC011, which uses a patient's own immune cells modified to attack lymphoma cells. It is for adults with follicular lymphoma that has returned or not responded to at least two prior therapies. The main goal is to see how many patients' tumor…
Phase: PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC